InterVene
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- $32M
Investors
- 8
About InterVene
InterVene, Inc.Founded in 2011 and headquartered in San Francisco, US, InterVene, Inc. specializes in creating medical devices to address chronic venous conditions.InterVene Inc. specializes in the development and manufacturing of advanced interventional devices aimed at treating chronic venous insufficiency (CVI) and post-thrombotic venous obstructions. Their flagship product, the Recana™ device, is engineered to efficiently de-bulk and recanalize chronic venous occlusions resulting from conditions such as deep vein thrombosis (DVT). The Recana™ device offers a novel approach to addressing the complications of CVI, which can lead to severe symptoms such as leg swelling, pain, and skin changes. InterVene's primary customer base includes healthcare facilities, vascular surgeons, and interventional specialists across the United States, where the product is currently undergoing clinical investigations.S.InterVene Inc. operates on a business-to-business (B2B) model, primarily engaging with hospitals and surgical centers that require innovative solutions for managing chronic venous conditions. The revenue structure revolves around sales of their Recana™ device, available through direct partnerships with medical facilities and distributors. Each transaction involves procurement agreements whereby healthcare providers acquire the devices for clinical use, thereby enhancing patient outcomes.In October 2024, InterVene, Inc. The company plans to utilize these funds for the final development of the Recana catheter system, initiation of clinical cases, regulatory submission, and market clearance in the United States, alongside initial commercialization and post-market clinical research. As part of their growth strategy, InterVene intends to expand its operations into new geographic regions following regulatory approvals, solidifying its market presence in areas with high demand for chronic venous treatments.
Who invested in InterVene
8 investors across 3 rounds
See all investors in InterVene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InterVene
Who invested in InterVene?
InterVene has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InterVene raised?
InterVene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did InterVene last raise money?
InterVene's most recent round on record is a Series A, in Oct 2024.
What does InterVene do?
InterVene is a medical devices & equipment company.
Where is InterVene headquartered?
InterVene is headquartered in San Francisco, US.
Which VCs invest in companies like InterVene?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at InterVene's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like InterVene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.